Aspira Pathlab & Diagnostics Limited (BOM: 540788)

Aspira Pathlab & Diagnostics Statistics

Total Valuation

Aspira Pathlab & Diagnostics has a market cap or net worth of INR 639.20 million. The enterprise value is 639.92 million.

Market Cap	639.20M
Enterprise Value	639.92M

Important Dates

The next estimated earnings date is Tuesday, February 11, 2025.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Aspira Pathlab & Diagnostics has 10.29 million shares outstanding. The number of shares has increased by 4.50% in one year.

Current Share Class	n/a
Shares Outstanding	10.29M
Shares Change (YoY)	+4.50%
Shares Change (QoQ)	+9.45%
Owned by Insiders (%)	85.11%
Owned by Institutions (%)	3.58%
Float	1.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.73
P/TBV Ratio	7.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.22.

Current Ratio	2.51
Quick Ratio	2.21
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+55.54%
50-Day Moving Average	60.75
200-Day Moving Average	39.46
Relative Strength Index (RSI)	40.48
Average Volume (20 Days)	2,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 24.09 million in cash and 24.81 million in debt, giving a net cash position of -720,000 or -0.07 per share.

Cash & Cash Equivalents	24.09M
Total Debt	24.81M
Net Cash	-720,000
Net Cash Per Share	-0.07
Equity (Book Value)	111.80M
Book Value Per Share	10.84
Working Capital	35.26M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Aspira Pathlab & Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.50%
Shareholder Yield	-4.50%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a